First interleukin-6 (IL-6) inhibitor to offer new therapeutic option for rheumatoid arthritis NUTLEY, N.J., July 29, 2008 /PRNewswire/ -- Roche today announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) by...
Source: http://www.drugs.com/new-drug-applications.html
Drugs.com - New Drug Applications